Seyfarth Shaw LLP has more than 850 attorneys and provides a broad range of legal services in the areas of intellectual property, labor and employment, employee benefits, litigation, corporate and real estate. With offices in Atlanta, Boston, Chicago, Houston, London, Los Angeles, Melbourne, New York, Sacramento, San Francisco, Shanghai, Sydney and Washington, D.C., Seyfarth’s clients include over 300 of the Fortune 500 companies and reflect virtually every industry and segment of the economy. A recognized leader in delivering value and innovation for legal services, Seyfarth’s acclaimed SeyfarthLean client service model has earned numerous accolades from a variety of highly respected third parties, including industry associations, consulting firms and media. For more information, please visit www.seyfarth.com.
Dean L. Fanelli, Ph.D. is a partner in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. Dr. Fanelli’s expertise lies in patent portfolio creation and management, counseling, technology transactions, due diligence, opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions, and inter partes review and post grant review proceedings. Dr. Fanelli also has significant experience with the interplay between patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, and financing for life sciences companies as well as ANDA analyses associated with Hatch-Waxman paragraph IV litigation.
Dr. Fanelli received his J.D. from The George Washington University Law School and received his Ph.D. in organic chemistry from Temple University, where he studied the syntheses of biologically active amino acids and amino acid derivatives under the supervision of Dr. Franklin A. Davis.
Jamaica Szeliga is a partner in the Litigation Department of Seyfarth Shaw LLP’s Washington, D.C. office.
Ms. Szeliga’s practice focuses primarily on intellectual property litigation relating to pharmaceutical, biotechnology, and chemical matters. She also litigates patent disputes involving other technologies, including medical devices, mechanical inventions, communications, and high tech products, and further has significant experience in design patent litigation.
With respect to litigation, Ms. Szeliga has participated in several bench and jury trials and managed litigations at all stages. As part of her experiences, Ms. Szeliga has drafted and argued dispositive motions, coordinated complex fact discovery, managed expert discovery, taken and defended fact and expert depositions, examined witnesses at trial, engaged in mediation and dispute resolution processes, and briefed multiple appeals. She also has been a member of several joint defense groups, and has litigated against such groups, particularly in the context of Hatch-Waxman ANDA matters.
Parithosh K. Tungaturthi is a patent agent in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. With over 12 years of experience, Dr. Tungaturthi focuses his practice in the areas of patent prosecution, due diligence and opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions. Dr. Tungaturthi’s practice also includes Hatch-Waxman litigation and FDA Regulatory and Compliance matters.
Dr. Tungaturthi has significant expertise in a broad range of disciplines including antibody engineering and therapeutics, cancer immunology, molecular diagnostics, genetic engineering, stem cell technology, pharmaceuticals, active pharmaceutical ingredients, formulations, drug delivery, vaccines, medical devices, and plant breeding and biotechnology. He also has experience in nanotechnology, polymer chemistry, organic and inorganic chemistry, biomaterials, and biofuels.
Prior to joining the firm, Dr. Tungaturthi worked at prominent law firms in the Washington, D.C. area and at the U.S. Patent and Trademark Office.
Dr. Tungaturthi earned his J.D. from The University of Baltimore School of Law. He received his Ph.D. in Molecular Biology and Immunology from Thomas Jefferson University and is a graduate of Louisiana State University, where he received his B.S. in Microbiology and conducted research in Organic Chemistry. Dr. Tungaturthi’s undergraduate and graduate research studies have been published in peer-reviewed scientific journals.